Leptin in autoimmune diseases

Metabolism: Clinical and Experimental

Volumn 64, Issue 1, 2015, Pages 92-104

  Procaccini, Claudio ^a   Pucino, Valentina ^a   Mantzoros, Christos S ^b,c,d   Matarese, Giuseppe ^e,f  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

^d BOSTON MEDICAL CENTER   (United States)

^e UNIVERSITY OF CHIETI   (Italy)

^f IRCCS MULTIMEDICA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CD45RA ANTIGEN; CD45RO ANTIGEN; CD71 ANTIGEN; INTERLEUKIN 2 RECEPTOR ALPHA; LEPTIN;

ADAPTIVE IMMUNITY; ARTICLE; AUTOIMMUNE DIABETES; AUTOIMMUNE DISEASE; AUTOIMMUNE THYROIDITIS; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CROHN DISEASE; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DIABETES MELLITUS; HUMAN; IMMUNE RESPONSE; IMMUNOPATHOGENESIS; INFLAMMATORY BOWEL DISEASE; INSULIN DEPENDENT DIABETES MELLITUS; LYMPHOCYTE PROLIFERATION; MULTIPLE SCLEROSIS; NONHUMAN; PRIORITY JOURNAL; PSORIASIS; REGULATORY T LYMPHOCYTE; RHEUMATOID ARTHRITIS; SYSTEMIC LUPUS ERYTHEMATOSUS; ULCERATIVE COLITIS; ANIMAL; AUTOIMMUNITY; IMMUNOLOGY; METABOLISM; OBESITY; PATHOLOGY;

ANIMALS; AUTOIMMUNE DISEASES; AUTOIMMUNITY; HUMANS; LEPTIN; OBESITY;

EID: 84924055669     PISSN: 00260495     EISSN: 15328600     Source Type: Journal    
DOI: 10.1016/j.metabol.2014.10.014     Document Type: Review

References (199)

1. Y. Zhang, R. Proenca, M. Maffei, M. Barone, L. Leopold, and J.M. Friedman Positional cloning of the mouse obese gene and its human homologue Nature 372 1994 425 432
2. J.S. Flier The adipocyte: storage depot or node on the energy information superhighway? Cell 80 1995 15 18
3. J.M. Friedman, and J.L. Halaas Leptin and the regulation of body weight in mammals Nature 395 1998 763 770
4. F. Chehab, M. Lim, and R. Lu Correction of the sterility defect in homozygous obese female mice by treatment with the human recombinant leptin Nat Genet 12 1996 318 320
5. B.D. Bennett, G.P. Solar, J.Q. Yuan, J. Mathias, G.R. Thomas, and W. Matthews A role for leptin and its cognate receptor in hematopoiesis Curr Biol 6 1996 1170 1180
6. M.R. Sierra-Honigmann, A.K. Nath, C. Murakami, G. García-Cardeña, A. Papapetropoulos, and W.C. Sessa Biological action of leptin as an angiogenic factor Science 281 1998 1683 1686
7. V. Pucino, V. De Rosa, C. Procaccini, and G. Matarese Regulatory T cells, leptin and angiogenesis Chem Immunol Allergy 99 2014 155 169
8. P. Ducy, M. Amling, S. Takeda, M. Priemel, A.F. Schilling, and F.T. Beil Leptin inhibits bone formation through a hypothalamic relay: a central control of bone mass Cell 100 2000 197 207
9. L. Berti, and S. Gammeltoft Leptin stimulates glucose uptake in C2C12 muscle cells by activation of ERK2 Mol Cell Endocrinol 157 1999 121 130
10. G.M. Lord, G. Matarese, J.K. Howard, R.J. Baker, S.R. Bloom, and R.I. Lechler Leptin modulates the T-cells immune response and reverses starvation-induced immunosuppression Nature 394 1998 897 901
11. G.M. Lord, G. Matarese, J.K. Howard, and R.I. Lechler The bioenergetics of the immune system Science 292 2001 855 856
12. D.A. Fraser, J. Thoen, J.E. Reseland, O. Førre, and J. Kjeldsen-Kragh Decreased CD4 + lymphocyte activation and increased interleukin-4 production in peripheral blood of rheumatoid arthritis patients after acute starvation Clin Rheumatol 18 1999 394 401
13. A. La Cava, and G. Matarese The weight of leptin in immunity Nat Rev Immunol 4 2004 371 379
14. C. Procaccini, E. Jirillo, and G. Matarese Leptin as an immunomodulator Mol Aspects Med 33 2012 35 45
15. A. Stofkova Leptin and adiponectin: from energy and metabolic dysbalance to inflammation and autoimmunity Endocr Regul 43 2009 157 168
16. R. Gómez, J. Conde, M. Scotece, J.J. Gómez-Reino, F. Lago, and O. Gualillo What's new in our understanding of the role of adipokines in rheumatic diseases? Nat Rev Rheumatol 7 2011 528 536
17. G. Matarese, V. Sanna, R.I. Lechler, N. Sarvetnick, S. Fontana, and S. Zappacosta Leptin accelerates autoimmune diabetes in female NOD mice Diabetes 51 2002 1356 1361
18. G. Matarese, A. Di Giacomo, V. Sanna, G.M. Lord, J.K. Howard, and A. Di Tuoro Requirement for leptin in the induction and progression of autoimmune encephalomyelitis J Immunol 166 2001 5909 5916
19. R.K. Chandra Cell-mediated immunity in genetically obese C57BL/6J (ob/ob) mice Am J Clin Nutr 33 1980 13 16
20. M.A. Mandel, and A.A. Mahmoud Impairment of cell-mediated immunity in mutation diabetic mice (db/db) J Immunol 120 1978 1375 1377
21. M. Ozata, I.C. Ozdemir, and J. Licinio Human leptin deficiency caused by a missense mutation: multiple endocrine defects, decreased sympathetic tone, and immune system dysfunction indicate new targets for leptin action, greater central than peripheral resistance to the effects of leptin, and spontaneous correction of leptin-mediated defects J Clin Endocrinol Metab 84 1999 3686 3695
22. I.S. Farooqi, G. Matarese, G.M. Lord, J.M. Keogh, E. Lawrence, and C. Agwu Beneficial effects of leptin on obesity, T cell hyporesponsiveness, and neuroendocrine/metabolic dysfunction of human congenital leptin deficiency J Clin Invest 110 2002 1093 1103
23. G. Matarese, C. La Rocca, H.S. Moon, J.Y. Huh, M.T. Brinkoetter, and S. Chou Selective capacity of metreleptin administration to reconstitute CD4 + T-cell number in females with acquired hypoleptinemia Proc Natl Acad Sci U S A 110 2013 E818 E827
24. Y. Zhang, J.T. Wilsey, C.D. Frase, M.M. Matheny, B.S. Bender, and S. Zolotukhin Peripheral but not central leptin prevents the immunosuppression associated with hypoleptinemia in rats J Endocrinol 174 2002 455 461
25. J.L. Chan, G. Matarese, G.K. Shetty, P. Raciti, I. Kelesidis, and D. Aufiero Differential regulation of metabolic, neuroendocrine, and immune function by leptin in humans Proc Natl Acad Sci U S A 103 2006 8481 8486
26. G. Matarese, S. Moschos, and C.S. Mantzoros Leptin in immunology J Immunol 174 2005 3137 3142
27. P. Mancuso, A. Gottschalk, S.M. Phare, M. Peters-Golden, N.W. Lukacs, and G.B. Huffnagle Leptin-deficient mice exhibit impaired host defense in Gram-negative pneumonia J Immunol 168 2002 4018 4024
28. P. Mancuso, C. Canetti, A. Gottschalk, P.K. Tithof, and M. Peters-Golden Leptin augments alveolar macrophage leukotriene synthesis by increasing phospholipase activity and enhancing group IVC iPLA2 (cPLA2γ) protein expression Am J Physiol 287 2004 L497 L502
29. S. Loffreda, S.Q. Yang, H.Z. Lin, C.L. Karp, M.L. Brengman, and D.J. Wang Leptin regulates proinflammatory immune responses FASEB J 12 1998 57 65
30. T. Gainsford, T.A. Willson, D. Metcalf, E. Handman, C. McFarlane, and A. Ng Leptin can induce proliferation, differentiation, and functional activation of hemopoietic cells Proc Natl Acad Sci U S A 93 1996 14564 14568
31. H. Zarkesh-Esfahani, G. Pockley, R.A. Metcalfe, M. Bidlingmaier, Z. Wu, and A. Ajami High-dose leptin activates human leukocytes via receptor expression on monocytes J Immunol 167 2001 4593 4599
32. F. Caldefie-Chezet, A. Poulin, A. Tridon, B. Sion, and M.P. Vasson Leptin: a potential regulator of polymorphonuclear neutrophil bactericidal action? J Leukoc Biol 69 2001 414 418
33. F. Caldefie-Chezet, A. Poulin, and M.P. Vasson Leptin regulates functional capacities of polymorphonuclear neutrophils Free Radic Res 37 2003 809 814
34. H. Zarkesh-Esfahani, A.G. Pockley, Z. Wu, P.G. Hellewell, A.P. Weetman, and R.J. Ross Leptin indirectly activates human neutrophils via induction of TNF-α J Immunol 172 2004 1809 1814
35. Z. Tian, R. Sun, H. Wei, and B. Gao Impaired natural killer (NK) cell activity in leptin receptor deficient mice: leptin as a critical regulator in NK cell development and activation Biochem Biophys Res Commun 298 2002 297 302
36. Y. Zhao, R. Sun, L. You, C. Gao, and Z. Tian Expression of leptin receptors and response to leptin stimulation of human natural killer cell lines Biochem Biophys Res Commun 300 2003 247 252
37. E. Papathanassoglou, K. El-Haschimi, X.C. Li, G. Matarese, T. Strom, and C. Mantzoros Leptin receptor expression and signaling in lymphocytes: kinetics during lymphocyte activation, role in lymphocyte survival, and response to high fat diet in mice J Immunol 176 2006 7745 7752
38. C. Martin-Romero, J. Santos-Alvarez, R. Goberna, and V. Sanchez-Margalet Human leptin enhances activation and proliferation of human circulating T lymphocytes Cell Immunol 199 2000 15 24
39. J.K. Howard, G.M. Lord, G. Matarese, S. Vendetti, M.A. Ghatei, and M.A. Ritter Leptin protects mice from starvation-induced lymphoid atrophy and increases thymic cellularity in ob/ob mice J Clin Invest 104 1999 1051 1059
40. V. De Rosa, C. Procaccini, G. Calì, G. Pirozzi, S. Fontana, and S. Zappacosta A key role of leptin in the control of regulatory T cell proliferation Immunity 26 2007 241 255
41. C. Procaccini, V. De Rosa, M. Galgani, L. Abanni, G. Calì, and A. Porcellini An oscillatory switch in mTOR kinase activity sets regulatory T cell responsiveness Immunity 33 2010 929 941
42. C. Procaccini, V. De Rosa, M. Galgani, F. Carbone, S. Cassano, and D. Greco Leptin-induced mTOR activation defines a specific molecular and transcriptional signature controlling CD4 + effector T cell responses J Immunol 189 2012 2941 2953
43. C. Procaccini, M. Galgani, V. De Rosa, and G. Matarese Intracellular metabolic pathways control immune tolerance Trends Immunol 33 2012 1 7
44. Y. Yu, Y. Liu, F.D. Shi, H. Zou, G. Matarese, and A. La Cava Cutting edge: leptin-induced RORγt expression in CD4 + T cells promotes Th17 responses in systemic lupus erythematosus J Immunol 190 2013 3054 3058
45. R. Milo, and A. Miller Revised diagnostic criteria of multiple sclerosis Autoimmun Rev 13 2014 518 524
46. R. Milo, and E. Kahana Multiple sclerosis: geoepidemiology, genetics and the environment Autoimmun Rev 9 2010 A387 A394
47. S. Sawcer, R.J.M. Franklin, and M. Ban Multiple sclerosis genetics Lancet Neurol 13 2014 700 709
48. K.L. Munger, T. Chitnis, and A. Ascherio Body size and risk of MS in two cohorts of US women Neurology 73 2009 1543 1550
49. A.K. Hedström, T. Olsson, and L. Alfredsson High body index before age 20 is associated with increased risk for multiple sclerosis men and women Mult Scler J 18 2012 1334 1336
50. K.L. Munger, J. Bentzen, B. Laursen, E. Stenager, N. Koch-henriksen, and T.I.A. Sørensen Childhood body mass index and multiple sclerosis risk: a long-term cohort study Mult Scler J 19 2013 1323 1329
51. A. Langer-gould, and B.E. Beaber Childhood obesity and risk of pediatric multiple sclerosis and clinically isolated syndrome Neurology 80 2013 548 552
52. A.K. Hedström, I. Lima Bomfim, L. Barcellos, M. Gianfrancesco, C. Schaefer, and I. Kockum Interaction between adolescent obesity and HLA risk genes in the etiology of multiple sclerosis Neurology 82 2014 865 872
53. G. Matarese, V. Sanna, A. Di Giacomo, G.M. Lord, J.K. Howard, and S.R. Bloom Leptin potentiates experimental autoimmune encephalomyelitis in SJL female mice and confers susceptibility to males Eur J Immunol 31 2001 1324 1332
54. V. Sanna, A. Di Giacomo, A. La Cava, R.I. Lechler, S. Fontana, and S. Zappacosta Leptin surge precedes onset of autoimmune encephalomyelitis and correlates with development of pathogenic T cell responses J Clin Invest 111 2003 241 250
55. V. De Rosa, C. Procaccini, A. La Cava, P. Chieffi, G.F. Nicoletti, and S. Fontana Leptin neutralization interferes with pathogenic T cell autoreactivity in autoimmune encephalomyelitis J Clin Invest 116 2006 447 455
56. M. Galgani, C. Procaccini, V. De Rosa, F. Carbone, P. Chieffi, and A. La Cava Leptin modulates the survival of autoreactive CD4 + T cells through the nutrient/energy-sensing mammalian target of rapamycin signaling pathway J Immunol 185 2010 7474 7479
57. S. Ouyang, H. Hsuchou, A.J. Kastin, P.K. Mishra, Y. Wang, and W. Pan Leukocyte infiltration into spinal cord of EAE mice is attenuated by removal of endothelial leptin signaling Brain Behav Immun 40 2014 61 73
58. G. Frisullo, M. Mirabella, F. Angelucci, M. Caggiula, R. Morosetti, and C. Sancricca The effect of disease activity on leptin, leptin receptor and suppressor of cytokine signalling-3 expression in relapsing-remitting multiple sclerosis J Neuroimmunol 192 2007 174 183
59. C. Lock, G. Hermans, R. Pedotti, A. Brendolan, E. Schadt, and H. Garren Gene-microarray analysis of multiple sclerosis lesions yields new targets validated in autoimmune encephalomyelitis Nat Med 8 2002 500 508
60. A.P. Batocchi, M. Rotondi, M. Caggiula, G. Frisullo, F. Odoardi, and V. Nociti Leptin as marker of multiple sclerosis activity in patients treated with interferon- J Neuroimmunol 139 2003 150 154
61. G. Matarese, P.B. Carrieri, A. La Cava, F. Perna, V. Sanna, and V. De Rosa Leptin increase in multiple sclerosis associates with reduced number of CD4 + CD25 + regulatory T cells Proc Natl Acad Sci U S A 102 2005 5150 5155
62. M. Feuerer, L. Herrero, D. Cipolletta, A. Naaz, J. Wong, and A. Nayer Lean, but not obese, fat is enriched for a unique population of regulatory T cells that affect metabolic parameters Nat Med 8 2009 930 939
63. S. Winer, Y. Chan, G. Paltser, D. Truong, H. Tsui, and J. Bahrami Normalization of obesity-associated insulin resistance through immunotherapy Nat Med 8 2009 921 929
64. D. Cipolletta, M. Feuerer, A. Li, N. Kamei, J. Lee, and S.E. Shoelson PPAR-γ is a major driver of the accumulation and phenotype of adipose tissue Treg cells Nature 486 2012 549 553
65. L. Piccio, J.L. Stark, and A.H. Cross Chronic calorie restriction attenuates experimental autoimmune encephalomyelitis J Leukoc Biol 8 2008 940 948
66. V.D. Longo, and L. Fontana Calorie restriction and cancer prevention: metabolic and molecular mechanisms Trends Pharmacol Sci 31 2010 89 98
67. A.I. Esquifino, P. Cano, V. Jimenez, R.A. Cutrera, and D.P. Cardinali Experimental allergic encephalomyelitis in male Lewis rats subjected to calorie restriction J Physiol Biochem 60 2004 245 252
68. A.I. Esquifino, P. Cano, V. Jimenez-Ortega, M.P. Fernandez-Mateos, and D.P. Cardinali Immune response after experimental allergic encephalomyelitis in rats subjected to calorie restriction J Neuroinflammation 4 2007 6
69. A. Cassinotti, P. Sarzi-Puttini, M. Fichera, Y. Shoenfeld, R. de Franchis, and S. Ardizzone Immunity, autoimmunity and inflammatory bowel disease Autoimmun Rev 13 2014 1 2
70. D.C. Baumgart, and W.J. Sandborn Crohn's disease Lancet 380 2012 1590 1605
71. I. Ordás, L. Eckmann, M. Talamini, D.C. Baumgart, and W.J. Sandborn Ulcerative colitis Lancet 380 2012 1606 1619
72. C. Abraham, and J.H. Cho Inflammatory bowel disease N Engl J Med 361 2009 2066 2078
73. J. Cosnes, C. Gower-Rousseau, P. Seksik, and A. Cortot Epidemiology and natural history of inflammatory bowel diseases Gastroenterology 140 2011 1785 1794
74. M.C. Harpsøe, S. Basit, M. Andersson, N.M. Nielsen, M. Frisch, and J. Wohlfahrt Body mass index and risk of autoimmune diseases: a study within the Danish National Birth Cohort Int J Epidemiol 2014 1 13
75. J.K. Hou, B. Abraham, and H. El-Serag Dietary intake and risk of developing inflammatory bowel disease: a systematic review of the literature Am J Gastroenterol 106 2011 563 573
76. M.D. Deboer, and Y. Li Puberty is delayed in male mice with dextran sodium sulfate colitis out of proportion to changes in food intake, body weight, and serum levels of leptin Pediatr Res 69 2011 34 39
77. M. Barbier, C. Cherbut, and A.C. Aube Elevated plasma leptin concentrations in early stages of experimental intestinal inflammation in rats Gut 43 1998 783 790
78. B. Siegmund, H.A. Lehr, and G. Fantuzzi Leptin: a pivotal mediator of intestinal inflammation in mice Gastroenterology 122 2002 2011 2025
79. B. Siegmund, J.A. Sennello, J. Jones-Carson, and F. Gamboni- Robertson Leptin receptor expression on T lymphocytes modulates chronic intestinal inflammation in mice Gut 53 2004 965 972
80. J.A. Senello, R. Fayad, M. Pini, M.E. Gove, and G. Fantuzzi Transplantation of wild-type white adipose tissue normalizes metabolic, immune and inflammatory alterations in leptin deficient ob/ob mice Cytokine 36 2006 261 266
81. U.P. Singh, N.P. Singh, H. Guan, B. Busbee, R.L. Price, and D.D. Taub The emerging role of leptin antagonist as potential therapeutic option for inflammatory bowel disease Int Rev Immunol 33 2014 23 33
82. M. Buyse, F. Berlioz, S. Guilmeau, A. Tsocas, T. Voisin, and G. Péranzi PepT1-mediated epithelial transport of dipeptides and cephalexin is enhanced by luminal leptin in the small intestine J Clin Invest 108 2001 1483 1494
83. M. Buyse, S.V. Sitaraman, X. Liu, A. Bado, and D. Merlin Luminal leptin enhances CD147/MCT-1-mediated uptake of butyrate in the human intestinal cell line Caco2-BBE J Biol Chem 277 2002 28182 28190
84. A. Blain, S. Cattan, L. Beaugerie, F. Carbonnel, J.P. Gendre, and J. Cosnes Crohn's disease clinical course and severity in obese patients Clin Nutr 21 2002 51 57
85. D.J. Hass, C.M. Brensinger, J.D. Lewis, and G.R. Lichtenstein The impact of increased body mass index on the clinical course of Crohn's disease Clin Gastroenterol Hepatol 4 2006 482 488
86. J. Barrenetxe, A.C. Villaro, L. Guembe, and I. Pascual Distribution of the long leptin receptor isoform in brush border, basolateral membrane, and cytoplasm of enterocytes Gut 50 2002 797 802
87. S. Sitaraman, X. Liu, L. Charrier, and L.H. Gu Colonic leptin: Source of a novel proinflammatory cytokine involved in IBD FASEB J 18 2004 696 698
88. M. Barbier, H. Vidal, P. Desreumaux, and L. Dubuquoy Overexpression of leptin mRNA in mesenteric adipose tissue in inflammatory bowel diseases Gastroenterol Clin Biol 27 2003 987 991
89. A. Tuzun, A. Uygun, and Z. Yesilova Leptin levels in the acute stage of ulcerative colitis J Gastroenterol Hepatol 19 2004 429 432
90. K. Karmiris, I.E. Koutroubakis, and C. Xidakis Circulating levels of leptin, adiponectin, resistin, and ghrelin in inflammatory bowel disease Inflamm Bowel Dis 12 2006 100 105
91. K. Karmiris, I.E. Koutroubakis, and E.A. Kouroumalis Leptin, adiponectin, resistin, and ghrelin - implications for inflammatory bowel disease Mol Nutr Food Res 52 2008 855 866
92. G. Biesiada, J. Czepiel, and A. Ptak-Belowska Expression and release of leptin and proinflammatory cytokines in patients with ulcerative colitis and infectious diarrhea J Physiol Pharmacol 63 2012 471 481
93. J.F. Caro, M.K. Sinha, and J.W. Kolaczynski Leptin: the tale of an obesity gene Diabetes 45 1996 1455 1462
94. M. Maffei, J. Halaas, and E. Ravussin Leptin levels in human and rodent: measurement of plasma leptin and ob RNA in obese and weight-reduced subjects Nat Med 1 1995 1155 1161
95. B.P. Fitzgerald, and C.J. McManus Photoperiodic versus metabolic signals as determinants of seasonal anestrus in the mare Biol Reprod 63 2000 335 340
96. B. Aurangzeb, S.T. Leach, D.A. Lemberg, and A.S. Day Assessment of nutritional status and serum leptin in children with inflammatory bowel disease J Pediatr Gastroenterol Nutr 52 2011 536 541
97. C. Pitzalis, S. Kelly, and F. Humby New learnings on the pathophysiology of RA from synovial biopsies Curr Opin Rheumatol 25 2013 334 344
98. R. Imrich The role of neuroendocrine system in the pathogenesis of rheumatic diseases Endocr Regul 36 2002 95 106
99. C. Procaccini, V. Pucino, V. De Rosa, G. Marone, and G. Matarese Neuro-endocrine networks controlling immune system in health and disease Front Immunol 5 2014 1 10
100. N. Busso, A. So, V. Chobaz-Peclat, C. Morard, E. Martinez-Soria, and D. Talabot-Ayer Leptin signaling deficiency impairs humoral and cellular immune responses and attenuates experimental arthritis J Immunol 168 2002 875 882
101. M. Otero, J.J. Gomez Reino, and O. Gualillo Synergistic induction of nitric oxide synthase type II: in vitro effect of leptin and interferon-gamma in human chondrocytes and ATDC5 chondrogenic cells Arthritis Rheum 48 2003 404 409
102. M.B. Goldring, and F. Berenbaum The regulation of chondrocyte function by proinflammatory mediators: prostaglandins and nitric oxide Clin Orthop Relat Res 427 2004 37 46
103. M. Otero, R. Lago, F. Lago, J.J. Reino, and O. Gualillo Signalling pathway involved in nitric oxide synthase type II activation in chondrocytes: synergistic effect of leptin with interleukin-1 Arthritis Res Ther 7 2005 581 591
104. G. Tian, J.N. Liang, Z.Y. Wang, and D. Zhou Emerging role of leptin in rheumatoid arthritis Clin Exp Immunol 1773 2014 557 570
105. M. Bokarewa, D. Bokarew, O. Hultgren, and A. Tarkowski Leptin consumption in the inflamed joints of patients with rheumatoid arthritis Ann Rheum Dis 62 2003 952 956
106. T. Yoshino, N. Kusunoki, N. Tanaka, K. Kaneko, Y. Kusunoki, and H. Endo Elevated serum levels of resistin, leptin, and adiponectin are associated with C-reactive protein and also other clinical conditions in rheumatoid arthritis Intern Med 50 2011 269 275
107. D. Xibille-Friedmann, C. Bustos-Bahena, S. Hernandez-Gongora, R. Burgos-Vargas, and J.L. Montiel-Hernandez Two-year follow-up of plasma leptin and other cytokines in patients with rheumatoid arthritis Ann Rheum Dis 69 2010 930 931
108. B. Targonska-Stepniak, M. Dryglewska, and M. Majdan Adiponectin and leptin serum concentrations in patients with rheumatoid arthritis Rheumatol Int 30 2010 731 737
109. K. Hamaguchi, A. Itabashi, Y. Kuroe, M. Nakano, E. Fujimoto, and T. Kato Analysis of adipose tissues and stromal vascular cells in a murine arthritis model Metabolism 61 2012 1687 1695
110. M. Otero, R. Lago, R. Gomez, F. Lago, C. Dieguez, and J.J. Gómez-Reino Changes in plasma levels of fat derived hormones adiponectin, leptin, resistin and visfatin in patients with rheumatoid arthritis Ann Rheum Dis 65 2006 1198 1201
111. B. Targonska-Stepniak, M. Majdan, and M. Dryglewska Leptin serum levels in rheumatoid arthritis patients: relation to disease duration and activity Rheumatol Int 28 2008 585 591
112. S. Hizmetli, M. Kisa, N. Gokalp, and M.Z. Bakici Are plasma and synovial fluid leptin levels correlated with disease activity in rheumatoid arthritis? Rheumatol Int 27 2007 335 338
113. P. Harle, P. Sarzi-Puttini, M. Cutolo, and R.H. Straub No change of serum levels of leptin and adiponectin during anti-tumour necrosis factor antibody treatment with adalimumab in patients with rheumatoid arthritis Ann Rheum Dis 65 2006 970 971
114. C. Popa, M.G. Netea, T.R. Radstake, P.L. van Riel, P. Barrera, and J.W. van der Meer Markers of inflammation are negatively correlated with serum leptin in rheumatoid arthritis Ann Rheum Dis 64 2005 1195 1198
115. H.J. Anders, M. Rihl, A. Heufelder, O. Loch, and M. Schattenkirchner Leptin serum levels are not correlated with disease activity in patients with rheumatoid arthritis Metabolism 48 1999 745 748
116. A. Seven, S. Guzel, M. Aslan, and V. Hamuryudan Serum and synovial fluid leptin levels and markers of inflammation in rheumatoid arthritis Rheumatol Int 29 2009 743 747
117. J.T. Giles, D.M. van der Heijde, and J.M. Bathon Association of circulating adiponectin levels with progression of radiographic joint destruction in rheumatoid arthritis Ann Rheum Dis 70 2011 1562 1568
118. J.T. Giles, M. Allison, C.O. Bingham III, W.M. Scott Jr.; and J.M. Bathon Adiponectin is a mediator of the inverse association of adiposity with radiographic damage in rheumatoid arthritis Arthritis Rheum 61 2009 1248 1256
119. R. Gunaydin, T. Kaya, A. Atay, N. Olmez, A. Hur, and M. Koseoglu Serum leptin levels in rheumatoid arthritis and relationship with disease activity South Med J 99 2006 1078 1083
120. N. Agmon-Levin, M. Mosca, M. Petri, and Y. Shoenfeld Systemic lupus erythematosus one disease or many? Autoimmun Rev 11 2012 593 595
121. M. Gatto, M. Zen, A. Ghirardello, S. Bettio, N. Bassi, and L. Iaccarino Emerging and critical issues in the pathogenesis of lupus Autoimmun Rev 12 2013 523 536
122. J.W. Dieker, J. van der Vlag, and J.H. Berden Triggers for antichromatin autoantibody production in SLE Lupus 11 2002 856 864
123. A. Rahman, and D.A. Isenberg Systemic lupus erythematosus N Engl J Med 358 2008 929 939
124. C.P. Chung, A.G. Long, J.F. Solus, Y.H. Rho, A. Oeser, and P. Raggi Adipocytokines in systemic lupus erythematosus: relationship to inflammation, insulin resistance and coronary atherosclerosis Lupus 18 2009 799 806
125. K.E. Sada, Y. Yamasaki, M. Maruyama, H. Sugiyama, M. Yamamura, and Y. Maeshima Altered levels of adipocytokines in association with insulin resistance in patients with systemic lupus erythematosus J Rheumatol 33 2006 1545 1552
126. B.H. Rovin, H. Song, L.A. Hebert, T. Nadasdy, G. Nadasdy, and D.J. Birmingham Plasma, urine, and renal expression of adiponectin in human systemic lupus erythematosus Kidney Int 68 2005 1825 1833
127. G. Matarese, E.H. Leiter, and A. La Cava Leptin in autoimmunity: many questions, some answers Tissue Antigens 70 2007 87 95
128. M. McMahon, B.J. Skaggs, L. Sahakian, J. Grossman, J. FitzGerald, and N. Ragavendra High plasma leptin levels confer increased risk of atherosclerosis in women with systemic lupus erythematosus, and are associated with inflammatory oxidised lipids Ann Rheum Dis 70 2011 1619 1624
129. A. Garcia-Gonzalez, L. Gonzalez-Lopez, I.C. Valera-Gonzalez, E.G. Cardona-Muñoz, M. Salazar-Paramo, and M. González-Ortiz Serum leptin levels in women with systemic lupus erythematosus Rheumatol Int 22 2002 138 141
130. M. Wislowska, M. Rok, K. Stepien, and A. Kuklo-Kowalska Serum leptin in systemic lupus erythematosus Rheumatol Int 28 2008 467 473
131. M. Vadacca, D. Margiotta, A. Rigon, F. Cacciapaglia, G. Coppolino, and A. Amoroso Adipokines and systemic lupus erythematosus: relationship with, metabolic syndrome and cardiovascular disease risk factors J Rheumatol 36 2009 295 297
132. W.D. Xu, M. Zhang, Y.J. Zhang, S.S. Liu, H.F. Pan, and D.Q. Ye Association between leptin and systemic lupus erythematosus Rheumatol Int 34 2014 559 563
133. Y. Liu, Y. Yu, G. Matarese, and A. La Cava Fasting-induced hypoletinemia expands functional regulatory T cells in systemic lupus erythematosus J Immunol 188 2013 2070 2073
134. Y. Fujita, T. Fujii, T. Mimori, T. Sato, T. Nakamura, and H. Iwao Deficient leptin signalling ameliorates systemic lupus erythematosus lesions in MRL/Mp - Faslpr mice J Immunol 192 2014 979 984
135. G. Amarilyo, N. Iikuni, F.D. Shi, A. Liu, G. Matarese, and A. La Cava Leptin promotes lupus T-cell autoimmunity Clin Immunol 149 2013 530 533
136. T. Tuomi, N. Santoro, S. Caprio, M. Cai, J. Weng, and L. Groop The many faces of diabetes: a disease with increasing heterogeneity Lancet 383 2014 1084 1094
137. S. Canivell, and R. Gomis Diagnosis and classification of autoimmune diabetes mellitus Autoimmun Rev 13 2014 403 407
138. C.C. Patterson, G.G. Dahlquist, E. Gyürüs, A. Green, and G. Soltész Incidence trends for childhood type 1 diabetes in Europe during 1989-2003 and predicted new cases 2005-20: a multicentre prospective registration study Lancet 373 2009 2027 2033
139. H.S. Moon, G. Matarese, A.M. Brennan, J.P. Chamberland, X. Liu, and C.G. Fiorenza Efficacy of metreleptin in obese patients with type 2 diabetes: cellular and molecular pathways underlying leptin tolerance Diabetes 60 2011 1647 1656
140. C.H. Lee, Y.G. Chen, J. Chen, P.C. Reifsnyder, D.V. Serreze, and M. Clare-Salzler Novel leptin receptor mutation in NOD/LtJ mice suppresses type 1 diabetes progression: II. Immunologic analysis Diabetes 55 2006 171 178
141. C.H. Lee, P.C. Reifsnyder, J.K. Naggert, C. Wasserfall, M.A. Atkinson, and J. Chen Novel leptin receptor mutation in NOD/LtJ mice suppresses type 1 diabetes progression: I. Pathophysiological analysis Diabetes 54 2005 2525 2532
142. K.M. Flegal, M.D. Carroll, C.L. Ogden, and L.R. Curtin Prevalence and trends in obesity among US adults, 1999-2008 JAMA 303 2010 235 241
143. T.J. Wilkin The accelerator hypothesis: weight gain as the missing link between type I and type II diabetes Diabetologia 44 2001 914 922
144. C. Johansson, U. Samuelsson, and J. Ludvigsson A high weight gain in early life is associated with an increased risk of type 1 (insulin-dependent) diabetes Diabetologia 37 1994 91 94
145. C.R. Pedersen, T. Bock, S.V. Hansen, M.W. Hansen, and K. Buschard High juvenile body weight and low insulin levels as markers preceding early diabetes in the BB rat Autoimmunity 17 1994 261 269
146. A. Oge, E. Isganaitis, J. Jimenez-Chillaron, C. Reamer, R. Faucette, and K. Barry In utero undernutrition reduces diabetes incidence in non-obese diabetic mice Diabetologia 50 2007 1099 1108
147. E. Hypponen, S.M. Virtanen, M.G. Kenward, M. Knip, and H.K. Akerblom Obesity, increased linear growth, and risk of type 1 diabetes in children Diabetes Care 23 2000 1755 1760
148. G.J. Bruining Association between infant growth before onset of juvenile type-1 diabetes and autoantibodies to IA-2 Lancet 356 2000 655 656
149. M. Kibirige, B. Metcalf, R. Renuka, and T.J. Wilkin Testing the accelerator hypothesis: the relationship between body mass and age at diagnosis of type 1 diabetes Diabetes Care 26 2003 2865 2870
150. P. Betts, J. Mulligan, P. Ward, B. Smith, and T.J. Wilkin Increasing body weight predicts the earlier onset of insulin-dependant diabetes in childhood: testing the "accelerator hypothesis" Diabet Med 22 2005 144 151
151. I. Knerr, J. Wolf, T. Reinehr, R. Stachow, M. Grabert, and E. Schober The "accelerator hypothesis": relationship between weight, height, body mass index and age at diagnosis in a large cohort of 9248 German and Austrian children with type 1 diabetes mellitus Diabetologia 48 2005 2501 2504
152. O. Kordonouri, and R. Hartmann Higher body weight is associated with earlier onset of type 1 diabetes in children: confirming the "Accelerator Hypothesis" Diabet Med 22 2005 1783 1784
153. R. Hermann, M. Knip, and R. Veijola Temporal changes in the frequencies of HLA genotypes in patients with type I diabetes - indication of an increased environmental pressure? Diabetologia 46 2003 420 425
154. P. Xu, J.P. Krischer, D. Cuthbertson, C. Greenbaum, and J.P. Palmer Role of insulin resistance in predicting progression to type 1 diabetes Diabetes Care 30 2007 2314 2320
155. S. Fourlanos, L.C. Harrison, and P.G. Colman The accelerator hypothesis and increasing incidence of type 1 diabetes Curr Opin Endocrinol Diabetes Obes 15 2008 321 325
156. S. Fourlanos, P. Narendran, G.B. Byrnes, P.G. Colman, and L.C. Harrison Insulin resistance is a risk factor for progression to type 1 diabetes Diabetologia 47 2004 1661 1667
157. M.I. Hawa, R. Bonfanti, C. Valeri, M. Delli Castelli, H. Beyan, and R.D. Leslie No evidence for genetically determined alteration in insulin secretion or sensitivity predisposing to type 1 diabetes: a study of identical twins Diabetes Care 28 2005 1415 1418
158. B. Mittendorfer, and S. Klein Absence of leptin triggers type 1 diabetes Nat Med 20 2014 705 706
159. R.J. Perry, X.M. Zhang, D. Zhang, N. Kumashiro, J.P. Camporez, and G.W. Cline Leptin reverses diabetes by suppression of the hypothalamic-pituitary-adrenal axis Nat Med 20 2014 759 763
160. X. Yu, B.H. Park, M.Y. Wang, Z.V. Wang, and R.H. Unger Making insulin-deficient type 1 diabetic rodents thrive without insulin Proc Natl Acad Sci U S A 105 2008 14070 14075
161. M.Y. Wang, L. Chen, G.O. Clark, Y. Lee, R.D. Stevens, and O.R. Ilkayeva Leptin therapy in insulin-deficient type I diabetes Proc Natl Acad Sci U S A 107 2010 4813 4819
162. A.J. Kruger, C. Yang, K.L. Lipson, S.C. Pino, J.H. Leif, and C.M. Hogan Leptin treatment confers clinical benefit at multiple stages of virally induced type 1 diabetes in BB rats Autoimmunity 44 2011 137 148
163. M. Naito, J. Fujikura, K. Ebihara, F. Miyanaga, H. Yokoi, and T. Kusakabe Therapeutic impact of leptin on diabetes, diabetic complications, and longevity in insulin-deficient diabetic mice Diabetes 60 2011 2265 2273
164. F.O. Nestle, D.H. Kaplan, and J. Barker Psoriasis N Engl J Med 361 2009 496 509
165. P.J. Mease Psoriatic arthritis: update on pathophysiology, assessment and management Ann Rheum Dis 70 Suppl. 1 2011 i77 i84
166. J. Hercogová, F. Ricceri, L. Tripo, T. Lotti, and F. Prignano Psoriasis and body mass index Dermatol Ther 23 2010 152 154
167. L. Naldi, L. Chatenoud, D. Linder, A. Belloni Fortina, and A. Peserico Cigarette smoking, body mass index, and stressful life events as risk factors for psoriasis: results from an Italian case control study J Invest Dermatol 125 2005 61 67
168. T. Henseler, and E. Christophers Disease concomitance in psoriasis J Am Acad Dermatol 32 1995 982 986
169. K.J. Zhu, C. Zhang, M. Li, C.Y. Zhu, G. Shi, and Y.M. Fan Leptin levels in patients with psoriasis: a meta-analysis Clin Exp Dermatol 38 2013 478 483
170. J. Klein, P.A. Permana, and M. Owecki What are subcutaneous adipocytes really good for? Exp Dermatol 16 2007 45 70
171. S. Frank, B. Stallmeyer, H. Kämpfer, N. Kolb, and J. Pfeilschifter Leptin enhances wound reepithelialization and constitutes a direct function of leptin in skin repair J Clin Invest 106 2000 501 509
172. A. Glasow, W. Kiess, U. Anderegg, A. Berthold, A. Bottner, and J. Kratzsch Expression of leptin (Ob) and leptin receptor (Ob-R) in human fibroblasts: regulation of leptin secretion by insulin J Clin Endocrinol Metab 86 2001 4472 4479
173. B. Stallmeyer, H. Kàmpfer, M. Podda, R. Kaufmann, J. Pfeilschifter, and S. Frank A novel keratinocyte mitogen: regulation of leptin and its functional receptor in skin repair J Invest Dermatol 117 1 2001 98 105
174. E. Toussirot, F. Aubin, and G. Dumoulin Relationships between adipose tissue and psoriasis, with or without arthritis Front Immunol 5 2014 368
175. Y. Wang, J. Chen, Y. Zhao, L. Geng, F. Song, and H.D. Chen Psoriasis is associated with increased levels of serum leptin Br J Dermatol 158 5 2008 1134 1135
176. A. Johnston, S. Arnadottir, J.E. Gudjonsson, A. Aphale, A.A. Sigmarsdottir, and S.I. Gunnarsson Obesity in psoriasis: leptin and resistin as mediators of cutaneous inflammation Br J Dermatol 159 2008 342 350
177. A.A. Cerman, S. Bozkurt, A. Sav, A. Tulunay, M.O. Elbaşi, and T. Ergun Serum leptin levels, skin leptin and leptin receptor expression in psoriasis Br J Dermatol 159 2008 820 826
178. H. Takahashi, H. Tsuji, and I. Takahashi Plasma adiponectin and leptin levels in Japanese patients with psoriasis Br J Dermatol 159 2008 1207 1208
179. Y.J. Chen, C.Y. Wu, J.L. Shen, S.Y. Chu, C.K. Chen, and Y.T. Chang Psoriasis independently associated with hyperleptinemia contributing to metabolic syndrome Arch Dermatol 144 2008 1571 1575
180. D.S.A. McLeod, and D.S. Cooper The incidence and prevalence of thyroid autoimmunity Endocrine 42 2012 252 265
181. S.H. Golden, K.A. Robinson, I. Saldanha, B. Anton, and P.W. Ladenson Clinical review: prevalence and incidence of endocrine and metabolic disorders in the United States: a comprehensive review J Clin Endocrinol Metab 94 2009 1853 1878
182. M.P.J. Vanderpump The epidemiology of thyroid disease Br Med Bull 99 2011 39 51
183. P. Caturegli, A. De Remigis, and N.R. Rose Hashimoto thyroiditis: clinical and diagnostic criteria Autoimmun Rev 13 2014 391 397
184. C.L. Burek, and M.V. Talor Environmental triggers of autoimmune thyroiditis J Autoimmun 33 2009 183 189
185. G. Cogni, and L. Chiovato An overview of the pathogenesis of thyroid autoimmunity Hormones (Athens) 12 2013 19 29
186. C.S. Fox, M.J. Pencina, R.B. D'Agostino, J.M. Murabito, E.W. Seely, and E.N. Pearce Relations of thyroid function to body weight: cross-sectional and longitudinal observations in a community-based sample Arch Intern Med 168 2008 587 592
187. A. Nyrnes, R. Jorde, and J. Sundsfjord Serum TSH is positively associated with BMI Int J Obes (Lond) 30 2006 100 105
188. H. Guo, X. Liu, C. Li, Y. Li, M. Sang, and Z. Shan Sustained high levels of serum leptin rather than IL-6 observed in patients with postpartum thyroiditis during their first postpartum year Endocrine 2014 10.1007/s12020-014-0176-3
189. N. Sera, N. Yokoyama, Y. Abe, A. Ide, M. Imaizumi, and T. Usa Thyroid hormones influence serum leptin levels in patients with Graves' disease during suppression of beta-adrenergic receptors Thyroid 10 2000 641 646
190. D.Z. Erickson, D.A. Harteneck, B.J. Erickson, C.M. Dutton, and R.S. Bahn Induction of leptin expression in orbital preadipocyte fibroblasts Thyroid 11 2001 221 226
191. P.F. Teixeira, M.D. Cabral, N.A. Silva, D.V. Soares, V.B. Braulio, and A.P. Couto Serum leptin in overt and subclinical hypothyroidism: effect of levothyroxine treatment and relationship to menopausal status and body composition Thyroid 19 2009 443 450
192. P. Marzullo, A. Minocci, M.A. Tagliaferri, G. Guzzaloni, A. Di Blasio, and C. De Medici Investigations of thyroid hormones and antibodies in obesity: leptin levels are associated with thyroid J Clin Endocrinol Metab 95 2014 3965 3972
193. K.K. Ong, D. Kuh, M. Pierce, and J.A. Franklyn Childhood weight gain and thyroid autoimmunity at age 60-64 years: the 1946 British Birth Cohort Study J Clin Endocrinol Metab 98 2014 1435 1442
194. S. Wang, S.E. Baidoo, Y. Liu, C. Zhu, J. Tian, and J. Ma T cell-derived leptin contributes to increased frequency of T helper type 17 cells in female patients with Hashimoto's thyroiditis Clin Exp Immunol 171 2012 63 68
195. N. Figueroa-Vega, M. Alfonso-Pérez, I. Benedicto, F. Sánchez-Madrid, R. González- Amaro, and M. Marazuela Increased circulating pro-inflammatory cytokines and Th17 lymphocytes in Hashimoto's thyroiditis J Clin Endocrinol Metab 95 2010 953 962
196. Y. Shi, H. Wang, Z. Su, J. Chen, Y. Xue, and S. Wang Differentiation imbalance of Th1/Th17 in peripheral blood mononuclear cells might contribute to pathogenesis of Hashimoto's thyroiditis Scand J Immunol 72 2010 250 255
197. L. Fontana, J.C. Eagon, M.E. Trujillo, P.E. Scherer, and S. Klein Visceral fat adipokine secretion is associated with systemic inflammation in obese humans Diabetes 56 2007 1010 1013
198. C. Procaccini, F. Carbone, M. Galgani, C. La Rocca, V. De Rosa, and S. Cassano Obesity and susceptibility to autoimmune diseases Expert Rev Clin Immunol 7 2011 287 294
199. H. Tilg, and A.R. Moschen Adipocytokines: mediators linking adipose tissue, inflammation and immunity Nat Rev Immunol 6 2006 772 783